1 completed, 1 terminated, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Cell to Cure ApS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ASCs in Recently Diagnosed Non-ischemic Heart Failure Allogeneic adipose tissue-derived mesenchymal stem cells, Cryostor CS10 - Non-Ischemic Heart Failure, Reduced Ejection Fraction Heart Failure | Phase 2 | Withdrawn | Cell to Cure ApS | 2026-03-01 | 2026-04-01 | |
| ASC - Autism Study Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®) - Autism Spectrum Disorder, Gastrointestinal Dysfunction | Phase 1 | Completed | Cell to Cure ApS | 10 | 2023-06-09 | 2024-09-26 |
| Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients. Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®) - Diabetic Foot Ulcer, Mesenchymal Stromal Cells | Phase 1 | Terminated | Cell to Cure ApS | 21 | 2022-12-15 | 2025-12-23 |
Autism Spectrum Disorder (1) · Diabetic Foot (1) · Heart Failure, Systolic (1) · Inflammatory Bowel Diseases (1)
Denmark (3)
Jens Kastrup (2) · Abbas A Qayyum, MD MSc PhD (1)
2025 (1)